Mesoblast Income Statement

Financials in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Revenue	65.38	17.2	5.9	7.5	10.21	7.43
Revenue Growth (YoY)	1053.16%	191.39%	-21.32%	-26.54%	37.35%	-76.88%
Cost of Revenue	47.54	39.94	39.72	52.82	63.57	85.73
Gross Profit	17.84	-22.74	-33.81	-45.32	-53.36	-78.3
Selling, General & Admin	49.84	39.31	24.98	27.48	27.21	30.87
Research & Development	41.08	-	-	-	-	-
Other Operating Expenses	-3.5	0.4	-0.82	-3.51	0	-0.07
Operating Expenses	87.42	39.7	24.16	23.97	27.21	30.8
Operating Income	-69.58	-62.44	-57.97	-69.29	-80.57	-109.1
Interest Expense	-26.04	-21.75	-20.66	-19.44	-16.91	-15.94
Interest & Investment Income	3.55	3.55	1.82	0.83	0	0.02
Currency Exchange Gain (Loss)	-0.11	-0.11	-0.08	-0.16	-0.54	1.47
Other Non Operating Income (Expenses)	1.3	-6.18	-1.57	-2.88	5.51	5.23
EBT Excluding Unusual Items	-90.86	-86.93	-78.45	-90.95	-92.5	-118.32
Asset Writedown	-	-	-	0.08	-	-
Other Unusual Items	-2.94	-14.89	-9.69	8.77	0.91	18.69
Pretax Income	-93.81	-101.81	-88.15	-82.1	-91.59	-99.63
Income Tax Expense	0.56	0.33	-0.19	-0.21	-0.24	-0.82
Net Income	-94.37	-102.14	-87.96	-81.89	-91.35	-98.81
Net Income to Common	-94.37	-102.14	-87.96	-81.89	-91.35	-98.81
Shares Outstanding (Basic)	1,283	1,208	987	778	683	605
Shares Outstanding (Diluted)	1,283	1,208	987	778	683	605
Shares Change (YoY)	14.57%	22.41%	26.87%	13.89%	12.86%	14.42%
EPS (Basic)	-0.07	-0.08	-0.09	-0.11	-0.13	-0.16
EPS (Diluted)	-0.07	-0.08	-0.09	-0.11	-0.13	-0.16
Free Cash Flow	-60.64	-50.63	-48.73	-63.53	-65.94	-102.4
Free Cash Flow Per Share	-0.05	-0.04	-0.05	-0.08	-0.10	-0.17
Gross Margin	27.29%	-132.22%	-	-	-	-
Operating Margin	-106.41%	-363.08%	-982.24%	-923.73%	-789.09%	-1467.53%
Profit Margin	-144.33%	-593.92%	-1490.27%	-1091.71%	-894.59%	-1329.18%
Free Cash Flow Margin	-92.74%	-294.42%	-825.63%	-846.99%	-645.76%	-1377.40%
EBITDA	-63.09	-58.18	-56.08	-66.84	-77.91	-106.52
EBITDA Margin	-96.49%	-	-	-	-	-
D&A For EBITDA	6.49	4.26	1.9	2.45	2.66	2.57
EBIT	-69.58	-62.44	-57.97	-69.29	-80.57	-109.1
EBIT Margin	-106.41%	-	-	-	-	-
Revenue as Reported	65.38	17.2	5.9	7.5	-	-

Updated Aug 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q